GlassScriptPhysician profile
Kristopher L Gates
NPI 1346653037
$7,165.02
in general payments reported to CMS, 2019-2025
34 companies · $1,747 in 2025
The $1,747 reported for 2025 was more than what 92% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,648 · 2022: $943 · 2023: $1,009 · 2024: $1,818 · 2025: $1,747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,573.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,176.80 | 2021-2025 | Proclaim, Ionicrf |
| Abbvie INC. | $1,125.48 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $938.96 | 2021-2025 | Xtampza, Belbuca |
| Pfizer INC. | $581.58 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $509.48 | 2021-2025 | Relistor |
| Biohaven Pharmaceuticals, INC. | $483.12 | 2021 | |
| Medtronic, INC. | $326.20 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Rialto Si Fusion System |
| Biohaven Pharmaceutical Holding Company LTD. | $274.51 | 2022 | |
| Amgen INC. | $227.86 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $205.43 | 2021-2025 | Ztlido |
| Globus Medical, INC. | $167.91 | 2025 | Senza |
| Nevro Corp. | $146.25 | 2021-2024 | Senza |
| Boston Scientific Corporation | $141.00 | 2022-2025 | Wavewriter Alpha Prime 16, General - Therapies |
| Lilly USA, LLC | $109.14 | 2021-2024 | Emgality |
| Teva Pharmaceuticals USA, INC. | $101.87 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $77.31 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $76.89 | 2024-2025 | |
| Biodelivery Sciences International, INC. | $72.78 | 2021 | |
| Vertos Medical, INC. | $61.57 | 2024 | Mild Device Kit |
| Azurity Pharmaceuticals, INC. | $41.77 | 2024 | Horizant |
| Averitas Pharma INC. | $38.25 | 2025 | Qutenza |
| Protega Pharmaceutials INC | $36.11 | 2023-2025 | Roxybond |
| Saluda Medical Americas, INC. | $29.97 | 2025 | Evoke |
| Upsher-Smith Laboratories LLC | $29.95 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.18 | 2021 | |
| Redhill Biopharma INC. | $23.82 | 2022 | |
| Merck Sharp & Dohme LLC | $21.99 | 2022 | |
| Eisai INC. | $19.49 | 2021 | |
| Medline Industries LP | $19.09 | 2024 | Medline, Medline Industries, INC. |
| Valinor Pharma, LLC | $18.49 | 2025 | Movantik |
| Almatica Pharma LLC | $18.07 | 2022 | |
| Hikma Pharmaceuticals USA | $14.39 | 2022 | |
| Stryker Corporation | $13.86 | 2025 | Mild Device Kit |
| Stimwave Technologies Incorporated | $11.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristopher Gates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.